medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Número 5

<< Anterior Siguiente >>

Ann Hepatol 2017; 16 (5)


Wait Time for Curative Intent Radio Frequency Ablation is Associated with Increased Mortality in Patients with Early Stage Hepatocellular Carcinoma

Brahmania M, Ahmed O, Kelley M, Kowgier M, Khalili K, Beecroft R, Renner EL, Wong D, Shah H, Feld J, Janssen HLA, Sherman M

Idioma: Ingles.
Referencias bibliográficas: 13
Paginas: 765-771
Archivo PDF: 183.41 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. El-Serag HB. Hepatocellular carcinoma. New Engl J Med 2011; 365: 1118-27.

  2. Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. The Oncologist 2010; 15: 5-13.

  3. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-2.

  4. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New Engl J Med 1996; 334: 693-9.

  5. European Association for Study of Liver; European Organization for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Can 2012; 48: 599-64.

  6. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134: 1752-63.

  7. Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Roberts JP, et al. Excellent Outcome Following Down-Staging of Hepatocellular Carcinoma Prior to Liver Transplantation: An Intention-to-Treat Analysis. Hepatology 2008; 48: 819-27.

  8. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Xiao JL, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Annals of Surgery 2006; 243: 321-8.

  9. Livraghi T, Meloni F, Stasi M Di, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47: 82-9.

  10. Llovet J, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, et al. Sorafenib in Advanced Hepatocellular Carcinoma. New Engl J Med 2008; 359: 378-90.

  11. Available from: https://www.cancercare.on.ca/cms/One. aspx?portalId=1377&pageId=8844. Last accessed March 15, 2017.

  12. Baldassarre FG, Baerlocher M, Beecroft R, Dawson L. Focal Tumour ablation: thermal ablation of hepatocellular carcinoma and metastases from colorectal carcinoma: evidence summary [Internet]. Cancer Care Ontario; 2014 Jul [cited 2014 Jul 28]. Available from: https://www.cancercare.on.ca/.

  13. Khalili K, Menezes R, Kim TK, Yazdi LK, Jang HJ, Sharma S, Feld J, et al. The effectiveness of ultrasound surveillance for hepatocellular carcinoma in a Canadian centre and determinants of its success. Canad J Gastroenterol Hepatol 2015; 29: 267-73.




2020     |     www.medigraphic.com